The GPA contains provisions on the award by Member States of medical counter-measures obtained through joint procurement, as well as on issues such as tender documents, decision-making on the award and signature of contracts. To date, only two joint procurement processes have been launched, the first on pandemic vaccines and the second on personal protective equipment, a topic that was highlighted during the ongoing Ebola crisis. The Commission will also have the task of analysing problems in national markets (e.g. B shortage of vaccines) and then submit them to the JPASC, which will decide if and when a new APJ procedure should be initiated. Within the framework of the APP, there are two important committees, namely the Joint Procurement Agreement Steering Committee (JPASC), which is responsible for general issues such as the nature of the medical counter-measures to be obtained and decisions on the order of procurement procedures, and the Steering Committee for Specific Procurement Procedures (SPPSC), whose decisions are technical and include the nature of the procurement procedure (e.g. B.B open tender, limited competitive dialogue, innovative partnership) and the nature of the contract to be used (e.g. B direct contract, framework, managed storage, reservation contract) as well as other considerations, for example. B the type of vaccine to buy, dosage, packaging, etc. In addition, it is important to go through clear selection criteria (for example. B on what basis are tenderers accepted/rejected?) as well as procurement criteria (e.g.B. On what basis should tenders be evaluated?) to decide.
You may have seen news of the UK`s non-participation in recent joint purchases of personal protective equipment, respirators and test kits at EU level in the face of the COVID-19 pandemic. The reasons for our non-participation remain a little unclear. However, you may be interested in learning a little more about common public procurement, hence a brief overview. The rules applicable to joint public procurement are not the EU public procurement directives, but the rules on procurement by the EU institutions. In practice, these are closely inspired by the procedures of EU procurement directives and contain provisions on the application of the negotiated procedure, with or without prior publication of a contract notice. Signatories to the Community procedure shall have the possibility to participate, on a case-by-case basis, in a specific common procurement procedure until a call for tenders is published. Participation in a procurement procedure shall not prevent Member States from carrying out independent procurement procedures, including those involving the same medical counter-measures or economic operators as those subject to a common market under the GPA. It studies the use of the European Joint Supply Agreement (JPA) for the organisation of the purchase of vaccines and medicines for pandemic preparedness. The paper aims to understand the current use of JPA in response to the Covid 19 pandemic. The importance and originality of this study is that it deals with an instrument, the JPA, which is largely neglected by lawyers, and examines how the provisions on the joint procurement of medical counter-measures referred to in Article 5 of Decision 1082/2013/EU on serious cross-border health risks could be extended to the joint procurement of innovative health technologies and the development of a euro The European Health Union.
On 29 April 2015, Public Health England organised a workshop in Luxembourg on joint procurement of medical counter-measures for the European Commission, with the following participants from different Directorates-General of the Commission, EMA, ECDC, WHO and industry. . . .